Loading organizations...
§ Private Profile · Jakarta, Jakarta Raya, Indonesia
VIDA is a technology company.
VIDA has raised $72.1M across 7 funding rounds.
Key people at VIDA.
VIDA has raised $72.1M in total across 7 funding rounds.
Vida Health builds a virtual care platform designed to address chronic health conditions, including obesity, metabolic disorders, and co-occurring mental and physical health challenges. The company integrates human-centric coaching, therapy, and clinical support with digital tools to provide personalized, continuous care, leveraging technology to foster engagement and better health outcomes for individuals.
The company was founded in 2014 by Stephanie Tilenius, whose prior executive roles at Google, PayPal, and eBay provided a deep understanding of technology and consumer platforms. Tilenius identified the critical need for a more integrated and accessible approach to chronic disease management, recognizing that traditional healthcare models often fail to address the interconnectedness of physical and mental well-being over time.
Vida Health primarily serves employers and health plans, offering a comprehensive solution to support their populations. The company's long-term vision is to transform how chronic conditions are managed by making personalized, collaborative care widely available, ultimately improving health and reducing the burden of disease through a connected, whole-person approach.
Key people at VIDA.
VIDA refers to multiple technology companies, with the most prominent being Vida (vida.io), an Austin-based AI company building an AI Agent Operating System for automating customer communications via voice, text, chat, and SMS. It serves enterprises in sectors like construction, healthcare, automotive, and telecom, solving workflow inefficiencies by enabling lifelike AI agents that handle calls, scheduling, lead qualification, and sales—resolving inquiries faster than human agents per analysis of 10,000+ conversations[2][6]. Recently raising $4M in Series A, it powers tens of thousands of AI agents, targeting small businesses, telecoms, and service providers for scalable, low-latency interactions[2].
Other entities include VIDA Diagnostics (vidalung.ai), a clinical imaging intelligence firm using AI for digital biomarkers in respiratory, cardiovascular, and oncology trials to accelerate therapies[3][4]; Vida Technologies (vidatele.com), a Singapore-founded hardware/tech firm focused on automation, sustainability, and OEM telecom partnerships with subsidiaries in Africa and India[1]; and a generic software developer (vidatechnologies.co.in)[5]. This analysis prioritizes the AI voice leader due to its funding momentum and ecosystem impact[2].
Vida (AI voice, vida.io) was founded by telecommunications veterans, emerging from expertise in telecom and SaaS to address automation gaps in customer service; it gained traction with rapid scaling to tens of thousands of AI agents and a $4M Series A to bolster leadership from pros at Textline, Inteliquent, and Sinch[2][6].
Vida Technologies (Singapore) originated in 2010 as Vida Resources Pte, trading commodities and consumer electronics; it pivoted in 2017 to brand-building and global OEM telecom partnerships, rebranded to Vida Technologies in 2020 with African expansion, and invested in projects like V-Flowtech energy storage and Tarana Wireless with MTN in 2021[1].
VIDA Diagnostics focuses on clinical imaging roots in respiratory diseases like COPD and asthma, expanding to cardio-oncology via AI biomarkers without detailed founder timelines in sources[3][4].
Vida (AI voice) rides the AI agent workforce trend, timing perfectly with generative AI's rise for enterprise automation; market forces like labor shortages and high call volumes favor its speed edge, influencing ecosystems by enabling SMBs/telecoms to scale without massive headcount—shaping omnichannel comms standards[2][6]. VIDA Diagnostics leverages AI in precision medicine, accelerating respiratory/cardio-oncology trials amid booming digital biomarker demand, aiding sponsors via data biobanks and site matching to cut trial sizes/costs[3][4]. Vida Technologies taps sustainable tech in emerging markets, bridging hardware innovation with digital transformation in Africa/India telecom[1]. Collectively, they amplify AI's role in automation, health, and global connectivity.
Vida (AI voice) is poised for explosive growth, expanding AI agents globally with Series A fuel amid AI workforce proliferation; expect deeper telecom/SMB penetration and multi-modal enhancements. VIDA Diagnostics will integrate new modalities/therapeutics via partnerships, solidifying trial efficiency leadership. Vida Technologies eyes further sustainable expansions. These VIDA entities, transforming connections from calls to clinical scans, position technology as the seamless enabler of business and health evolution—catalysts in a digital-first era[1][2][4][6].
VIDA has raised $72.1M in total across 7 funding rounds.
VIDA's investors include Trammell Venture Partners, StillMark, Timechain, Cherry Ventures, Alpha JWC Ventures, DST Global, Fuse Venture Partners, Han River Partners, Insignia Ventures Partners, Y Combinator, David Vélez, OSF Ventures.
VIDA has raised $72.1M across 7 funding rounds. Most recently, it raised $4.0M Series A in November 2025.
